Key facts
- TRIP’s last known valuation is $144.3M (Apr 2025).
- It has raised $80.8M; the latest was Secondary Transaction - Private ($5.7M) in Jan 2026.
- Notable investors include Coefficient Capital, Maria Raga, 029 Group, Alessandra Ambrosio, Ashley Graham — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for TRIP
- ·The full record, as it builds
Funding rounds
No funding rounds for TRIP are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About TRIP
Producer of beverages and oils intended for CBD hemp and extracts for medicinal and recreational purposes. The company specializes in producing various CBD-infused beverages used for relaxing, getting rid of anxiety, and treating anti-inflammatory diseases, allowing customers to get CBD oils for smaller everyday stresses.
- Sector
- Consumer Products and Services (B2C)
- HQ
- London, United Kingdom
- Founded
- 2019
- Employees
- 186
- Website
- drink-trip.com/
- Ownership
- Privately Held (backing)
TRIP doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in TRIP shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on TRIP in its N-PORT filings yet. We sweep new filings monthly.